The pro-inflammatory cytokines TNFα and IL-6 have been shown to trigger phosphorylation of IRS-1, thus exerting an inhibitory action on insulin signaling; accordingly, genetic ablation either of TNFα or of its receptor can improve insulin resistance caused by obesity in rodent models [103]. The gene discussed is INS; the disease is obesity disorder.